SCHEMBL3743262

SCHEMBL3743262

O=C(O)c1ccnc(N2CCC(O)CC2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.67
KDM4C Q9H3R0 10/20 0.50
KDM4A O75164 4/20 0.50
KDM5A P29375 8/20 0.48
KDM5B Q9UGL1 6/20 0.48
KDM2B Q8NHM5 3/20 0.47
PROKR1 Q8TCW9 4/20 0.46
FGFR1 P11362 1/20 0.46
PTGER4 P35408 1/20 0.46
OPRD1 P41143 1/20 0.45
DPP4 P27487 2/20 0.45
DPP8 Q6V1X1 1/20 0.45
DPP9 Q86TI2 1/20 0.45
KDM4E B2RXH2 1/20 0.45
KDM6B O15054 1/20 0.45
TET3 O43151 1/20 0.45
BBOX1 O75936 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
KDM5C P41229 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3738805 0.87 PIK3CA (0.65) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL16966428 0.87 PIK3CA (0.65) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL30775157 0.84 PIK3CA (0.61) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL29139855 0.84 PIK3CA (0.61) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL1494841 0.84 PIK3CA (0.62) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL1516867 0.84 PIK3CA (0.74) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL31143236 0.84 PIK3CA (0.74) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL12552657 0.83 PIK3CA (0.60) PIK3CAKDM4CKDM4AKDM5AKDM5B
SCHEMBL20950150 0.83 PIK3CA (0.60) PIK3CAKDM4CKDM4AKDM5AKDM5B
Hydrochloric Acid SCHEMBL1252523 0.83 PIK3CA (0.72) PIK3CAKDM4CKDM4AKDM5AKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311754-A1 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase ARQULE, INC. (US) 2010-12-09 US disclosed
US-7829560-B2 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase ARQULE, INC. (US) 2010-11-09 US disclosed
US-20080032967-A1 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase ARQULE, INC. 2008-02-07 US disclosed
EP-1615919-B1 7-([1,4]DIOXAN-2-YL)-BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS HOFFMANN LA ROCHE (CH) 2007-08-22 EP disclosed
WO-2006010082-A1 1,4-DISUBSTITUTED NAPHTALENES AS INHIBITORS OF P38 MAP KINASE ARQULE, INC. (US) 2006-01-26 WO disclosed
US-6872833-B2 Adenosine receptor ligands HOFFMANN-LA ROCHE INC. (US) 2005-03-29 US disclosed
US-20040204584-A1 ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311754-A1 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase MAPK1, MAPK7, MAP3K1 PIK3CA 3537/4885KDM4C 4011/4885KDM4A 4206/4885
US-20040204584-A1 ADENOSINE RECEPTOR LIGANDS ADORA1, ADORA2A, ADORA3 PIK3CA 1855/4885KDM4C 4701/4885KDM4A 4494/4885
US-20080032967-A1 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase MAPK1, MAPK8, MAPK4 PIK3CA 2806/4885KDM4C 4381/4885KDM4A 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.